Importance of standardized treatment on community-acquired infection

CAP standard therapy

Authors

  • You-Ning Liu Department of Respiratory Disease, General Hospital of Chinese PLA, Beijing, China

DOI:

https://doi.org/10.4103/2225-6482.141745

References

Rüden H, Gastmeier P, Daschner FD, Schumacher M. Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP). Infection 1997;25:199-202.

McLaws ML, Gold J, King K, Irwig LM, Berry G. The prevalence of nosocomial and community-acquired infections in Australian hospitals. Med J Aust 1988;149:582-90.

Wang LR, Cai J, Shi MF. The incidence analysis of community-acquired infections and hospital-acquired infection. Zhejiang Yufang Yixue 2005;17:19-20.

Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S27-72.

Chinese Society of Respiratory Diseases. Expert consensus on mycoplasma pneumoniae pneumonia treatment in adults. Zhonghua Jiehe He Huxi Zazhi 2010;33: 643-5.

Downloads

Published

2014-09-25

How to Cite

1.
Liu YN. Importance of standardized treatment on community-acquired infection: CAP standard therapy. Community Acquir Infect. 2014;1. doi:10.4103/2225-6482.141745

Issue

Section

Editorial

Downloads

Download data is not yet available.